|
US2016151490A1
|
|
Methods and compositions for treating cancer
|
|
AU2014218470A1
|
|
Use of bone marrow cells for long term culture of pancreatic islet cells.
|
|
EP2389443A2
|
|
Retroviral vectors encoding multiple highly homologous non-viral polypeptides and the use of same
|
|
AU2007321983A1
|
|
Use of bone marrow cells for long term culture of pancreatic islet cells
|
|
EP2038248A2
|
|
Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer
|
|
EP1946117A1
|
|
P66-shc as predictive marker in cancer treatment
|
|
US2008249028A1
|
|
Thyrotropin-Releasing Hormone Analogs and Method of Use
|
|
AU2004282598A1
|
|
Shc proteins as therapeutic targets in proliferative diseases
|
|
AU2003231092A1
|
|
Bi-specific antigen-binding compositions and related methods
|
|
WO03091398A2
|
|
Compositions and methods for stem cell delivery
|
|
AU2003228225A1
|
|
SHC protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
|
|
WO03015705A2
|
|
In situ immunization
|
|
US7820718B1
|
|
Combinations of ceramide and chemotherapeutic agents for inducing cell death and uses thereof in treating cancer
|
|
US6107020A
|
|
Model for protective and pathogenic roles of HIV-1 env-directed antibody dependent cellular cytotoxicity interaction with viral load, and uses thereof
|
